跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERC betahistine dihydrochloride 8 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
SERC betahistine dihydrochloride 8 mg tablet blister pack
Approved
STANDARD
SERC betahistine dihydrochloride 8 mg tablet blister pack
Viatris Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
1f3c8c59121016cf
Company
Viatris Pty Ltd
Type
Standard
Approval Details
Approval Id
1f3c8c59121016cf
Product Name
SERC betahistine dihydrochloride 8 mg tablet blister pack
Artg Id
61688
Artg Name
SERC betahistine dihydrochloride 8 mg tablet blister pack
Sponsor
Viatris Pty Ltd
Company Detail Path
/organization/viatris-pty-ltd
Artg Date
1997-11-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
1f3c8c59121016cf
Type
Standard
Back to TGA Approvals
